129 related articles for article (PubMed ID: 12502930)
1. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
2. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.
Xu Z; Wang W; Deng CX; Man YG
Int J Biol Sci; 2009; 5(1):82-96. PubMed ID: 19173015
[TBL] [Abstract][Full Text] [Related]
3. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarrays for testing basal biomarkers in familial breast cancer cases.
Dufloth RM; Matos I; Schmitt F; Zeferino LC
Sao Paulo Med J; 2007 Jul; 125(4):226-30. PubMed ID: 17992394
[TBL] [Abstract][Full Text] [Related]
5. Improving the diagnosis of ductal carcinoma in situ with microinvasion without immunohistochemistry: An innovative method with H&E-stained and multiphoton microscopy images.
Han X; Liu Y; Zhang S; Li L; Zheng L; Qiu L; Chen J; Zhan Z; Wang S; Ma J; Kang D; Chen J
Int J Cancer; 2024 May; 154(10):1802-1813. PubMed ID: 38268429
[TBL] [Abstract][Full Text] [Related]
6. Single-cell heterogeneity in ductal carcinoma in situ of breast.
Gerdes MJ; Gökmen-Polar Y; Sui Y; Pang AS; LaPlante N; Harris AL; Tan PH; Ginty F; Badve SS
Mod Pathol; 2018 Mar; 31(3):406-417. PubMed ID: 29148540
[TBL] [Abstract][Full Text] [Related]
7. Breast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.
Mahooti S; Porter K; Alpaugh ML; Ye Y; Xiao Y; Jones S; Tellez JD; Barsky SH
Oncotarget; 2010 Jun; 1(2):131-147. PubMed ID: 21297224
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Breast Cancer Res; 2004; 6(1):R1-7. PubMed ID: 14680494
[TBL] [Abstract][Full Text] [Related]
9. Preinvasive breast cancer.
Sgroi DC
Annu Rev Pathol; 2010; 5():193-221. PubMed ID: 19824828
[TBL] [Abstract][Full Text] [Related]
10. In situ malignant transformation and progenitor-mediated cell budding: two different pathways for breast ductal and lobular tumor invasion.
Man YG; Izadjoo M; Song G; Stojadinovic A
J Cancer; 2011; 2():401-12. PubMed ID: 21811518
[TBL] [Abstract][Full Text] [Related]
11. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of p63 as a marker of breast myoepithelial cells.
Batistatou A; Stefanou D; Arkoumani E; Agnantis NJ
In Vivo; 2003; 17(6):573-6. PubMed ID: 14758723
[TBL] [Abstract][Full Text] [Related]
13. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
Ding Y; Ruan Q
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
[TBL] [Abstract][Full Text] [Related]
14. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
Hill CB; Yeh IT
Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
[TBL] [Abstract][Full Text] [Related]
15. Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.
Dewar R; Fadare O; Gilmore H; Gown AM
Arch Pathol Lab Med; 2011 Apr; 135(4):422-9. PubMed ID: 21466356
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
Laakso M; Loman N; Borg A; Isola J
Mod Pathol; 2005 Oct; 18(10):1321-8. PubMed ID: 15990899
[TBL] [Abstract][Full Text] [Related]
17. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain.
Kalof AN; Tam D; Beatty B; Cooper K
J Clin Pathol; 2004 Jun; 57(6):625-9. PubMed ID: 15166269
[TBL] [Abstract][Full Text] [Related]
18. Keratin expression in breast cancers.
Shao MM; Chan SK; Yu AM; Lam CC; Tsang JY; Lui PC; Law BK; Tan PH; Tse GM
Virchows Arch; 2012 Sep; 461(3):313-22. PubMed ID: 22851038
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis, prevention, diagnosis and treatment of breast cancer.
Shah R; Rosso K; Nathanson SD
World J Clin Oncol; 2014 Aug; 5(3):283-98. PubMed ID: 25114845
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
